Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhTSH for thymopoiesis in adults with hypothyroidism and T-cell deficiency
NL-OMON20628Phase 2Recruiting
- Sponsor
- Erasmus MC
- Start
- Mar 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of thyrotropin alfa in T-cell immunodeficiency and hypothyroidism (2 arms), sponsored by Erasmus MC. Primary endpoints: Change in peripheral T-cell subpopulations and Change in thymic output. Started Mar 2010; status: recruiting.
02
Drugs
thyrotropin alfa
03
Conditions
T-cell immunodeficiencyhypothyroidism
Beyond the preview
Go deeper on NL-OMON20628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON20628.